Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 774

1.

Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.

Ohigashi H, Ishikawa O, Eguchi H, Takahashi H, Gotoh K, Yamada T, Yano M, Nakaizumi A, Uehara H, Tomita Y, Nishiyama K.

Ann Surg. 2009 Jul;250(1):88-95. doi: 10.1097/SLA.0b013e3181ad65cc.

PMID:
19561477
2.

Feasibility and efficacy of combination therapy with preoperative and postoperative chemoradiation, extended pancreatectomy, and postoperative liver perfusion chemotherapy for locally advanced cancers of the pancreatic head.

Ohigashi H, Ishikawa O, Eguchi H, Sasaki Y, Yamada T, Noura S, Murata K, Takachi K, Miyashiro I, Doki Y, Imaoka S, Kasugai T, Nishiyama K.

Ann Surg Oncol. 2005 Aug;12(8):629-36. Epub 2005 Jun 22.

PMID:
15968497
3.

Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.

Coia L, Hoffman J, Scher R, Weese J, Solin L, Weiner L, Eisenberg B, Paul A, Hanks G.

Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):161-7.

PMID:
8083109
4.

Liver perfusion chemotherapy for selected patients at a high-risk of liver metastasis after resection of duodenal and ampullary cancers.

Noda T, Ohigashi H, Ishikawa O, Eguchi H, Yamada T, Sasaki Y, Yano M, Imaoka S.

Ann Surg. 2007 Nov;246(5):799-805.

PMID:
17968172
5.

Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.

Allen AM, Zalupski MM, Robertson JM, Eckhauser FE, Simone D, Brown D, Hejna G, Normolle D, Lawrence TS, McGinn CJ.

Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1461-7.

PMID:
15275733
6.

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.

Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JE, Pisters PW, Evans DB.

Ann Surg Oncol. 2001 Mar;8(2):123-32.

PMID:
11258776
7.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
8.

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA.

Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1293-302.

PMID:
11955742
9.

Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.

Le Scodan R, Mornex F, Partensky C, Mercier C, Valette PJ, Ychou M, Roy P, Scoazec JY.

Am J Clin Oncol. 2008 Dec;31(6):545-52. doi: 10.1097/COC.0b013e318172d5c5.

PMID:
19060585
10.

Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.

Small W Jr, Berlin J, Freedman GM, Lawrence T, Talamonti MS, Mulcahy MF, Chakravarthy AB, Konski AA, Zalupski MM, Philip PA, Kinsella TJ, Merchant NB, Hoffman JP, Benson AB, Nicol S, Xu RM, Gill JF, McGinn CJ.

J Clin Oncol. 2008 Feb 20;26(6):942-7. doi: 10.1200/JCO.2007.13.9014.

PMID:
18281668
11.

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

Stokes JB, Nolan NJ, Stelow EB, Walters DM, Weiss GR, de Lange EE, Rich TA, Adams RB, Bauer TW.

Ann Surg Oncol. 2011 Mar;18(3):619-27. doi: 10.1245/s10434-010-1456-7. Epub 2011 Jan 7.

PMID:
21213060
12.

Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.

Valentini V, Coco C, Picciocchi A, Morganti AG, Trodella L, Ciabattoni A, Cellini F, Barbaro B, Cogliandolo S, Nuzzo G, Doglietto GB, Ambesi-Impiombato F, Cosimelli M.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):664-74.

PMID:
12062610
13.

Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.

Lind PA, Isaksson B, Almström M, Johnsson A, Albiin N, Byström P, Permert J.

Acta Oncol. 2008;47(3):413-20. Epub 2007 Sep 20.

PMID:
17882555
14.

Survival after chemoradiation in resected pancreatic cancer: the impact of adjuvant gemcitabine.

Baschnagel A, Shah C, Margolis J, Nadeau L, Stein J, Jury R, Robertson JM.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e331-5. doi: 10.1016/j.ijrobp.2012.01.008. Epub 2012 Mar 13.

PMID:
22420967
15.

Perioperative intra-arterial and systemic chemotherapy for pancreatic cancer.

Takamori H, Kanemitsu K, Hirota M, Ikeda O, Tanaka H, Beppu T, Yamashita Y, Oya N, Baba H.

Ann Surg Oncol. 2011 Apr;18(4):1110-5. doi: 10.1245/s10434-010-1384-6. Epub 2010 Nov 3.

PMID:
21046268
16.

Postoperative gemcitabine alone and concurrent with radiation therapy in locally advanced pancreatic carcinoma.

Ozkok S, Demirci S, Yalman D, Zeytunlu M, Nart D, Yuzer Y, Coker A, Goker E.

Tumori. 2010 Jul-Aug;96(4):560-7.

17.

A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.

Myerson RJ, Valentini V, Birnbaum EH, Cellini N, Coco C, Fleshman JW, Gambacorta MA, Genovesi D, Kodner IJ, Picus J, Ratkin GA, Read TE.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1299-308.

PMID:
11483342
18.

Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer.

Takahashi H, Ohigashi H, Ishikawa O, Gotoh K, Yamada T, Nagata S, Tomita Y, Eguchi H, Doki Y, Yano M.

Ann Surg. 2012 Jan;255(1):95-102. doi: 10.1097/SLA.0b013e31823d813c.

PMID:
22123160
19.

A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.

Talamonti MS, Small W Jr, Mulcahy MF, Wayne JD, Attaluri V, Colletti LM, Zalupski MM, Hoffman JP, Freedman GM, Kinsella TJ, Philip PA, McGinn CJ.

Ann Surg Oncol. 2006 Feb;13(2):150-8. Epub 2006 Jan 19.

20.

The feasibility of dose escalation using concurrent radiation and 5-fluorouracil therapy following pancreaticoduodenectomy for pancreatic carcinoma.

Regine WF, John WJ, McGrath P, Strodel WE, Mohiuddin M.

J Hepatobiliary Pancreat Surg. 2000;7(1):53-7.

PMID:
10982592

Supplemental Content

Support Center